NCT02912234View on ClinicalTrials.gov

Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Venous Thromboembolism
Interventions
DRUG

Apixaban

Multiple-dose clarithromycin and single-dose Apixaban

DRUG

Clarithromycin

Multiple-dose clarithromycin and single-dose Apixaban

Trial Locations (1)

78744

Ppd Development, Llc, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT02912234 - Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants | Biotech Hunter | Biotech Hunter